$THMO
ThermoGenesis Holdings, Inc.

2015 Q2 Form 10-K Financial Statement

#000143774916038939 Filed on September 21, 2016

View on sec.gov

Income Statement

Concept 2015 Q2 2015 2014 Q2
Revenue $3.700M $16.04M $3.840M
YoY Change -3.65% 0.34% -7.47%
Cost Of Revenue $2.820M $11.29M $2.670M
YoY Change 5.62% 11.8% -7.61%
Gross Profit $880.0K $4.749M $1.170M
YoY Change -24.79% -19.32% -6.4%
Gross Profit Margin 23.78% 29.6% 30.47%
Selling, General & Admin $2.060M $13.67M $3.380M
YoY Change -39.05% 19.3% 25.65%
% of Gross Profit 234.09% 287.83% 288.89%
Research & Development $1.210M $5.939M $1.070M
YoY Change 13.08% 71.25% 37.18%
% of Gross Profit 137.5% 125.06% 91.45%
Depreciation & Amortization $340.0K $1.351M $400.0K
YoY Change -15.0% 36.05% 185.71%
% of Gross Profit 38.64% 28.45% 34.19%
Operating Expenses $3.270M $19.61M $4.450M
YoY Change -26.52% 31.37% 27.87%
Operating Profit -$2.390M -$14.86M -$3.280M
YoY Change -27.13% 64.37% 47.09%
Interest Expense $10.00K $14.00K $10.00K
YoY Change 0.0% 40.0% -150.0%
% of Operating Profit
Other Income/Expense, Net $7.000K
YoY Change
Pretax Income -$2.380M -$14.85M -$3.270M
YoY Change -27.22% 64.4% 36.25%
Income Tax $0.00 -$400.0K
% Of Pretax Income
Net Earnings -$2.380M -$14.85M -$2.870M
YoY Change -17.07% 72.08% 19.58%
Net Earnings / Revenue -64.32% -92.58% -74.74%
Basic Earnings Per Share
Diluted Earnings Per Share -$11.90M -$74.25M -$15.94M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.360M $3.360M $14.81M
YoY Change -77.31% -77.31% 115.26%
Cash & Equivalents $3.357M $3.360M $14.81M
Short-Term Investments
Other Short-Term Assets $160.0K $160.0K $220.0K
YoY Change -27.27% -27.27% -4.35%
Inventory $4.598M $4.600M $5.606M
Prepaid Expenses
Receivables $5.133M $5.130M $4.693M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.25M $13.25M $25.33M
YoY Change -47.68% -47.69% 55.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.937M $2.940M $2.298M
YoY Change 27.81% 27.83% 3.98%
Goodwill $13.20M $13.25M
YoY Change -0.45%
Intangibles $21.30M $21.93M
YoY Change -2.89%
Long-Term Investments
YoY Change
Other Assets $79.00K $80.00K $81.00K
YoY Change -2.47% 0.0% 62.0%
Total Long-Term Assets $37.51M $37.51M $37.56M
YoY Change -0.15% -0.13% 1561.99%
TOTAL ASSETS
Total Short-Term Assets $13.25M $13.25M $25.33M
Total Long-Term Assets $37.51M $37.51M $37.56M
Total Assets $50.76M $50.76M $62.89M
YoY Change -19.29% -19.29% 239.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.079M $5.080M $3.590M
YoY Change 41.48% 41.5% 15.43%
Accrued Expenses $710.0K $710.0K $600.0K
YoY Change 18.33% 18.33% 25.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.946M $7.950M $6.380M
YoY Change 24.55% 24.61% 23.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $268.0K $270.0K $169.0K
YoY Change 58.58% 58.82% 181.67%
Total Long-Term Liabilities $268.0K $270.0K $169.0K
YoY Change 58.58% 58.82% 181.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.946M $7.950M $6.380M
Total Long-Term Liabilities $268.0K $270.0K $169.0K
Total Liabilities $15.86M $15.86M $14.19M
YoY Change 11.73% 11.77% 172.36%
SHAREHOLDERS EQUITY
Retained Earnings -$137.7M -$122.8M
YoY Change 12.09%
Common Stock $2.000K $40.00K
YoY Change -95.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.90M $34.90M $48.70M
YoY Change
Total Liabilities & Shareholders Equity $50.76M $50.76M $62.89M
YoY Change -19.29% -19.29% 239.38%

Cashflow Statement

Concept 2015 Q2 2015 2014 Q2
OPERATING ACTIVITIES
Net Income -$2.380M -$14.85M -$2.870M
YoY Change -17.07% 72.08% 19.58%
Depreciation, Depletion And Amortization $340.0K $1.351M $400.0K
YoY Change -15.0% 36.05% 185.71%
Cash From Operating Activities -$1.330M -$10.65M -$1.740M
YoY Change -23.56% 35.9% 200.0%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K $587.0K -$70.00K
YoY Change -28.57% 46.02% 40.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$50.00K -$587.0K -$80.00K
YoY Change -37.5% 1050.98% 60.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $129.0K $10.10M
YoY Change -100.81%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K -189.0K 10.06M
YoY Change -100.5% -101.2% -100700.0%
NET CHANGE
Cash From Operating Activities -1.330M -10.65M -1.740M
Cash From Investing Activities -50.00K -587.0K -80.00K
Cash From Financing Activities -50.00K -189.0K 10.06M
Net Change In Cash -1.430M -11.43M 8.240M
YoY Change -117.35% -244.26% -1387.5%
FREE CASH FLOW
Cash From Operating Activities -$1.330M -$10.65M -$1.740M
Capital Expenditures -$50.00K $587.0K -$70.00K
Free Cash Flow -$1.280M -$11.24M -$1.670M
YoY Change -23.35% 36.39% 215.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 kool Approval For Grant In Amount For Clinical Trial
ApprovalForGrantInAmountForClinicalTrial
10000000
CY2016Q1 kool Consecutive Days Of Weighted Average Trading Price
ConsecutiveDaysOfWeightedAverageTradingPrice
P10D
CY2016Q2 kool Convertible Debt Gross
ConvertibleDebtGross
12500000
CY2016 kool Derivative Liability Additions
DerivativeLiabilityAdditions
4282000
CY2016 kool Derivative Obligation Related To Issuance Of Warrants
DerivativeObligationRelatedToIssuanceOfWarrants
4282000
CY2015 kool Derivative Obligation Related To Issuance Of Warrants
DerivativeObligationRelatedToIssuanceOfWarrants
CY2016Q1 kool Duration Of Moving Average Price
DurationOfMovingAveragePrice
P20D
CY2016 kool Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
2607000
CY2015 kool Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
CY2016 kool Effective Income Tax Rate Reconciliation Unbenefitted Net Operating Losses And Credits Amount
EffectiveIncomeTaxRateReconciliationUnbenefittedNetOperatingLossesAndCreditsAmount
3391000
CY2015 kool Effective Income Tax Rate Reconciliation Unbenefitted Net Operating Losses And Credits Amount
EffectiveIncomeTaxRateReconciliationUnbenefittedNetOperatingLossesAndCreditsAmount
5091000
CY2016 kool Equipment Acquired By Capital Lease
EquipmentAcquiredByCapitalLease
CY2015 kool Equipment Acquired By Capital Lease
EquipmentAcquiredByCapitalLease
208000
CY2016Q2 kool Future Amortization Expense Finite Lived Intangible Assets
FutureAmortizationExpenseFiniteLivedIntangibleAssets
951000
CY2016 kool Gain Loss On Cashless Exercise Of Warrants
GainLossOnCashlessExerciseOfWarrants
-1039000
CY2015 kool Gain Loss On Cashless Exercise Of Warrants
GainLossOnCashlessExerciseOfWarrants
CY2016 kool Gain Losses On Warrant Modifications
GainLossesOnWarrantModifications
-149000
CY2015 kool Gain Losses On Warrant Modifications
GainLossesOnWarrantModifications
CY2016Q1 kool Gross Proceeds From Financing Transaction
GrossProceedsFromFinancingTransaction
15000000
CY2016 kool Income Tax Benefit
IncomeTaxBenefit
0
CY2016 kool Inventory Change In Reserve
InventoryChangeInReserve
566000
CY2015 kool Inventory Change In Reserve
InventoryChangeInReserve
162000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5133000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4448000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4935000
CY2016 kool Maximum Period Of Agreement
MaximumPeriodOfAgreement
P21Y
CY2016Q1 kool Net Proceeds From Financing Transaction
NetProceedsFromFinancingTransaction
7300000
CY2016Q1 kool Net Short Term Investment Benchmark
NetShortTermInvestmentBenchmark
2100000
CY2016 kool Number Of Suppliers
NumberOfSuppliers
2
CY2015 kool Number Of Suppliers
NumberOfSuppliers
3
CY2016Q1 kool Number Of Warrants Percentage Of Shares Issued Or To Be Issued
NumberOfWarrantsPercentageOfSharesIssuedOrToBeIssued
0.8
CY2016 kool Payments Of Derivative Obligations Extinguishment
PaymentsOfDerivativeObligationsExtinguishment
159000
CY2016Q1 kool Percent Of Stock Price
PercentOfStockPrice
1.25
CY2016Q1 kool Period After Benchmark Reached
PeriodAfterBenchmarkReached
P15D
CY2015Q3 kool Short Term Investment Minimum
ShortTermInvestmentMinimum
2000000
CY2016Q2 kool Tax Benefits Related To Stock Options Included In Valuation Allowance
TaxBenefitsRelatedToStockOptionsIncludedInValuationAllowance
219000
CY2016 kool Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
18000
CY2015 kool Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
539000
CY2016Q1 kool Warrant Expiration Period
WarrantExpirationPeriod
P5Y
CY2016Q2 kool Working Capital
WorkingCapital
7301000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2648000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5079000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3169000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188569000
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
172579000
CY2016 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
7262000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
660000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
710000
CY2016 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4434000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
49000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46000
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6127000
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
800000
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6127000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
438000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
458000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8673138
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
472818
CY2016Q2 us-gaap Assets
Assets
49899000
CY2015Q2 us-gaap Assets
Assets
50757000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
12843000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
13251000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5835000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3357000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14811000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2478000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11454000
CY2016Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8
CY2016Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3529412
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3010687
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2027386
CY2016Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2367000
CY2015Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2143000
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45892000
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42408000
CY2016Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7641000
CY2016Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
160000
CY2016Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
220000
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3010687
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2027386
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18620000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14915000
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Credit Risk</div></div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company&#x2019;s customers. The Company believes that adequate </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has not experienced significant credit related losses.</div></div></div></div></div>
CY2016Q2 us-gaap Convertible Debt
ConvertibleDebt
2489000
CY2016Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
2489000
CY2015Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
9185000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
11293000
CY2016Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9851000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
783000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
635000
CY2016Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
874000
CY2015Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
916000
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
-283000
CY2015Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
447000
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41023000
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38317000
CY2016Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1345000
CY2015Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1479000
CY2016Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
7358000
CY2015Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
8088000
CY2015 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75
CY2016 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.015
CY2015 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.015
CY2015 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
CY2016 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.8
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2015Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7641000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7641000
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2016 us-gaap Depreciation
Depreciation
630000
CY2015 us-gaap Depreciation
Depreciation
850000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1168000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1351000
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3395000
CY2015 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
CY2016Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
4282000
CY2015Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2016Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
670000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.57
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.36
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-29000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
58000
CY2015 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
449000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
705000
CY2016 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
CY2016 us-gaap Gross Profit
GrossProfit
2744000
CY2015 us-gaap Gross Profit
GrossProfit
4749000
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2015 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
117000
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1005000
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
591000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
358000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
49000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
78000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
197000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
269000
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1956000
CY2015Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2016000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
951000
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1425000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-795000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8231000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10695000
CY2016Q2 us-gaap Goodwill
Goodwill
13195000
CY2015Q2 us-gaap Goodwill
Goodwill
13195000
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2015Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21886000
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20821000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21295000
CY2016 us-gaap Interest Expense
InterestExpense
1864000
CY2015 us-gaap Interest Expense
InterestExpense
14000
CY2016Q2 us-gaap Inventory Net
InventoryNet
3593000
CY2015Q2 us-gaap Inventory Net
InventoryNet
4598000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6300000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5046000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
233000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
69000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-33000
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2420000
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1410000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1956000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
459000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
148000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-256000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
105000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-375000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-254000
CY2016 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
160000
CY2015 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-76000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
64000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
41000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
86000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-54000
CY2016Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
21826000
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1437000
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
874000
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32000
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-63000
CY2016Q2 us-gaap Liabilities
Liabilities
17626000
CY2015Q2 us-gaap Liabilities
Liabilities
15855000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49899000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50757000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5542000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7946000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12824000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-189000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-710000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-587000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9625000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10649000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-18588000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-14852000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7723000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016 us-gaap Operating Expenses
OperatingExpenses
13609000
CY2015 us-gaap Operating Expenses
OperatingExpenses
19608000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-10865000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-14859000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
993000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
428000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
260000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
305000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
657000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
652000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
78000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
79000
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-63000
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1662000
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1527000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1284000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
268000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
1031000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
CY2016 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
159000
CY2015 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
129000
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
961000
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
710000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
587000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
246000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
163000
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclassification</div></div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certain account totals and other figures from prior year have been reclassified to conform to current period presentation.</div></div></div></div></div>
CY2016 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
18000000
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2463000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
627000
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
498000
CY2016Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
566000
CY2016 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
287000
CY2015 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
168000
CY2016 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
129000
CY2015 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
39000
CY2016 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
97000
CY2015 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
258000
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
CY2016 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
67000
CY2015 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
60000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3230000
CY2016 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
1109000
CY2015 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7410000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7872000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2962000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2937000
CY2016 us-gaap Registration Payment Arrangement Gains And Losses
RegistrationPaymentArrangementGainsAndLosses
-1100000
CY2015 us-gaap Registration Payment Arrangement Gains And Losses
RegistrationPaymentArrangementGainsAndLosses
CY2016Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
7500000
CY2016 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
6444000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5939000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156262000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137674000
CY2016Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
3.40
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
11929000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
16042000
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2148000
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2974000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
742000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1247000
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.75
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.40
CY2016Q1 us-gaap Share Price
SharePrice
4
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
735294
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
24000
CY2016Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2500000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2464000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
414000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
32273000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
34902000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
48698000
CY2016Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
160000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but not limited to, the allowance for doubtful accounts, slow-moving inventory reserves, depreciation, warranty costs, assumptions made in valuing equity instruments issued for services or acquisitions, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company&#x2019;s consolidated financial statements. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying consolidated financial statements through the date of issuance.</div></div></div></div></div>
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3484000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2455548
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2017597

Files In Submission

Name View Source Status
0001437749-16-038939-index-headers.html Edgar Link pending
0001437749-16-038939-index.html Edgar Link pending
0001437749-16-038939.txt Edgar Link pending
0001437749-16-038939-xbrl.zip Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img.jpg Edgar Link pending
kool-20160630.xml Edgar Link completed
kool-20160630.xsd Edgar Link pending
kool-20160630_cal.xml Edgar Link unprocessable
kool-20160630_def.xml Edgar Link unprocessable
kool-20160630_lab.xml Edgar Link unprocessable
kool-20160630_pre.xml Edgar Link unprocessable
kool20160630_10k.htm Edgar Link pending
kool20160630_10kimg002.gif Edgar Link pending
kool20160630_10kimg003.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending